Grown Rogue International (GRUSF) Net Income (2009 - 2026)
Grown Rogue International's (GRUSF) quarterly Net Income came in at -$2.2 million in Q1 2026, down 393.92% year-on-year from $753047.5 in Q1 2025, and up 100.0% quarter-over-quarter from -$5914.4 billion in Q4 2025.
Grown Rogue International (GRUSF) Net Income (2009 - 2026) Analysis & Trends
Grown Rogue International's Net Income history runs 18 years deep, the most recent figure standing at -$2.2 million for Q1 2026.
- On a quarterly basis, Net Income fell 393.92% year-over-year to -$2.2 million in Q1 2026; TTM through Mar 2026 was -$3079.3 billion, a 76040449.01% decrease from a year earlier, with the FY2025 full-year figure at -$2.1 million, up 72.91% from the prior year.
- Net Income advanced to -$2.2 million in Q1 2026 per GRUSF's latest filing, from -$5914.4 billion in the prior quarter.
- Across five years, Net Income topped out at $2835.1 billion in Q3 2025 and bottomed at -$5914.4 billion in Q4 2025.
- The 5-year median for Net Income is $411979.0 (2023), against an average of -$205.3 billion.
- Biggest YoY gain for Net Income was 579639028.52% in 2025; the steepest drop was 483173825.05% in 2025.
- Year by year, Net Income stood at $122811.1 in 2022, then jumped by 245.27% to $424032.7 in 2023, then jumped by 188.68% to $1.2 million in 2024, then tumbled by 483173825.05% to -$5914.4 billion in 2025, then surged by 100.0% to -$2.2 million in 2026.
- Per Business Quant, the three latest GRUSF Net Income figures stand at -$2.2 million (Q1 2026), -$5914.4 billion (Q4 2025), and $2835.1 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | -2.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.21 Mn |
| Dec 31, 2025 | -5,914.43 Bn |
| Sep 30, 2025 | 2,835.15 Bn |
| Jun 30, 2025 | 1.42 Mn |
| Mar 31, 2025 | 753,047.52 |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | -489,123.29 |
| Jun 30, 2024 | -5.54 Mn |
| Mar 31, 2024 | -3.09 Mn |
| Dec 31, 2023 | 424,032.67 |
| Oct 31, 2023 | -925,449.37 |
| Jul 31, 2023 | 567,497.16 |
| Apr 30, 2023 | 411,979.00 |
| Jan 31, 2023 | 439,303.63 |
| Jan 31, 2022 | 122,811.08 |
| Oct 31, 2021 | 877.00 Bn |
| Jul 31, 2021 | 4.47 Mn |
| Jan 31, 2021 | -995,789.00 |
| Oct 31, 2020 | -122,401.00 |
| Jul 31, 2020 | -3.67 Mn |